Literature DB >> 16103045

Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function.

Margot Ernst1, Stefan Bruckner, Stefan Boresch, Werner Sieghart.   

Abstract

Comparative models of the extracellular and transmembrane domains of GABAA receptors in the agonist-free state were generated based on the recently published structures of the nicotinic acetylcholine receptor. The models were validated by computational methods, and their reliability was estimated by analyzing conserved and variable elements of the cys-loop receptor topology. In addition, the methodological limits in the interpretation of such anion channel receptor models are discussed. Alignment ambiguities in the helical domain were resolved for helix 3 by placing two gaps into the linker connecting helices 2 and 3. The resulting models were shown to be consistent with a wide range of pharmacological and mutagenesis data from GABAA and glycine receptors. The loose packing of the models results in a large amount of solvent-accessible space and offers a natural explanation for the rich pharmacology and the great flexibility of these receptors that are known to exist in numerous drug-induced conformational states. Putative drug binding pockets found within and between subunits are described, and amino acid residues important for the action and subtype selectivity of volatile and intravenous anesthetics, barbiturates, and furosemide are shown to be part of these pockets. The entire helical domain, however, seems to be crucial not only for binding of drugs but also for transduction of binding to gating or of allosteric modulation. These models can now be used to design new experiments for clarification of pharmacological and structural questions as well as for investigating and visualizing drug induced conformational changes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103045     DOI: 10.1124/mol.105.015982

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  48 in total

1.  The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6β22 and 6β2 GABA(A) receptor channel gating and expression.

Authors:  Ciria C Hernandez; Katharine N Gurba; Ningning Hu; Robert L Macdonald
Journal:  J Physiol       Date:  2011-09-19       Impact factor: 5.182

Review 2.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Neurosteroids allosterically modulate binding of the anesthetic etomidate to gamma-aminobutyric acid type A receptors.

Authors:  Guo-Dong Li; David C Chiara; Jonathan B Cohen; Richard W Olsen
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

Review 4.  Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol.

Authors:  Richard W Olsen; Guo-Dong Li; Martin Wallner; James R Trudell; Edward J Bertaccini; Erik Lindahl; Keith W Miller; Ronald L Alkana; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2013-10-24       Impact factor: 3.455

Review 5.  GABAA receptor: Positive and negative allosteric modulators.

Authors:  Richard W Olsen
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

6.  Investigating the putative binding-mode of GABA and diazepam within GABA A receptor using molecular modeling.

Authors:  Suqin Ci; Tianrui Ren; Zhiguo Su
Journal:  Protein J       Date:  2008-02       Impact factor: 2.371

7.  Structural basis for alcohol modulation of a pentameric ligand-gated ion channel.

Authors:  Rebecca J Howard; Samuel Murail; Kathryn E Ondricek; Pierre-Jean Corringer; Erik Lindahl; James R Trudell; R Adron Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

8.  Deciphering the binding mode of Zolpidem to GABA(A) α₁ receptor - insights from molecular dynamics simulation.

Authors:  R S K Vijayan; Dhananjay Bhattacharyya; Nanda Ghoshal
Journal:  J Mol Model       Date:  2011-07-07       Impact factor: 1.810

9.  Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors.

Authors:  Guo-Dong Li; David C Chiara; Jonathan B Cohen; Richard W Olsen
Journal:  J Biol Chem       Date:  2010-01-18       Impact factor: 5.157

10.  Pentobarbital produces activation and block of {alpha}1{beta}2{gamma}2S GABAA receptors in rapidly perfused whole cells and membrane patches: divergent results can be explained by pharmacokinetics.

Authors:  Kevin J Gingrich; Paul M Burkat; William A Roberts
Journal:  J Gen Physiol       Date:  2009-02       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.